Addressing Pharmacy challenges at home and abroad
Paul Sinclair’s progression through the ranks of the International Pharmaceutical Federation (FIP) demonstrates the impact and influence he’s had in representing the pharmacy profession on a global scale. In this Australian Health Journal interview, Paul talks about the 4 themes in the upcoming FIP Congress in Brisbane this month. He also talks about the challenges facing pharmacy with remuneration, professional service delivery and the workforce coming out of the COVID era.
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
Hair’s-breadth endoscopes to detect plaque
This coming World Heart Day (29th September 2021), Australian Health Journal’s People in Health Care series, releases a segment on Dr Jiawen Li.
Dr Jiawen Li is an inventor and highly adaptable engineer leading the intravascular imaging program at the Institute of Photonics and Advanced Sensing (IPAS). She has developing an imaging device can be inserted into blood vessels to provide high quality 3D images to help scientists better understand the causes of heart attack and heart disease progression, and could lead to improved treatment and prevention.
Global collaboration in pulmonary fibrosis research
Pulmonary fibrosis is a lung disease that occurs when lung tissue becomes damaged and scarred. The debilitating and fatal disease ended the life of an Australian man 8 years ago.
His son led philanthropic efforts to establish the connection between 2 Australian organisations; Lung Foundation Australia and Centre for Research Excellence in Pulmonary Fibrosis and the US based, Three Lakes Foundation. The three organisations recently announced a collaboration to create a global network for PF research.
Redefining diversity in clinical trials
Ensuring inclusion, diversity, equity and patient input in the development of novel drugs and medical devices has become well accepted in health care. However appropriate implementation of these elements has been a challenge for many. Only by implementing these conscious inputs can patient outcomes be improved and health disparities in marginalised groups be addressed.
Australian Health Journal spoke to Gillian Mason, Consumer and Community Involvement Lead at Hunter Medical Research Institute in Newcastle, NSW on this topic discussed at the recent ARCS Conference in Sydney.
GP lens on Aboriginal health and COVID-19
The COVID-19 pandemic rolled through 2020 and the first half of 2021 without major lockdowns in regional communities, however recently that changed. The concern is now on vaccination rates in communities across Australia.
First Nation Aboriginal communities are at greater risk of outbreaks and transmission with low vaccination rates because of supply issues and changing advice rather than hesitancy.